Clinical Trial Update: Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis [Phase 3]

View source ↗

Summary

Phase 3 study assessing safety and efficacy of bimatoprost in Japanese patients with chemotherapy-induced eyelash hypotrichosis has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eyelash Hypotrichosis

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Eyelash Hypotrichosis | Phase 3 | Status: COMPLETED | Results posted: 2013-07-09